CVS Health posts $2B profit in Q4

CVS Health recorded $2 billion in profit in the fourth quarter of 2023, a 12% decline year over year driven by increased pressure in its Medicare Advantage business. 

In the fourth quarter and full year earnings report issued Feb. 7, CVS reported $8.4 billion in net income for 2023, up 93% over 2022. 

Total revenue in the fourth quarter was $93.8 billion, up around 12% from the same time period last year. For 2023, total revenue was $357.8 billion, up around 11% year over year. 

The company reported adjusted earnings per share of $8.74 for 2023. The company cut its earnings guidance for 2024 based on rising costs in the Medicare Advantage business to $8.30 per share. 

Healthcare benefits 

  • In its insurance segment, CVS Health posted year-end revenue of $105.6 billion, up 16% year over year. 
  • Adjusted operating income in the segment declined 26% in the fourth quarter year over year, due to increased enrollment in individual business and increasing Medicare Advantage costs. 
  • CVS reported a medical benefit ratio of 88.5% in the fourth quarter, up from 85.8% last year, driven by increased outpatient and supplemental benefit use in Medicare Advantage, according to the report.
     

Healthcare services 

  • Revenues from CVS' pharmacy benefit and healthcare provider business increased 10.3% in 2023, for full-year revenue of $186.8 billion in 2023. The acquisitions of Signify and Oak Street Health and growth in specialty pharmacy drove the increase, the company said. 
  • Total adjusted income in the segment increased 7.8% year over year to $7.3 billion in 2023. 

Pharmacy and consumer wellness 

  • CVS' retail segment reported a 7.5% increase in revenue in 2023, to $116.8 billion. 
  • The company reported an 8.7% decrease in income in the segment in 2023, declining to $6 billion. The drop was driven by increasing pharmacy reimbursement pressure and declines in COVID-19 vaccines and testing administered at CVS' pharmacies. 

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Articles We Think You'll Like